Lam Research Corporation $LRCX Stock Bought by CX Institutional

Key Points

• CX Institutional more than doubled its Lam Research stake in the third quarter, adding 30,609 shares to own 56,104 shares valued at approximately $18.4 million. Institutional investors collectively hold 84.61% of LRCX.
• Lam Research reported strong quarterly results, with EPS of $1.82 versus the $1.69 consensus and revenue of $6.72 billion, up 30% year over year. The company also raised its quarterly dividend from $0.26 to $0.33 per share.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $364.01. Shares recently traded at $347.49, while several firms set targets ranging from $350 to $500.

CX Institutional increased its position in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 120.1% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 56,104 shares of the semiconductor company's stock after purchasing an additional 30,609 shares during the period. CX Institutional's holdings in Lam Research were worth $18,431,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in LRCX. Bayban purchased a new position in shares of Lam Research during the 4th quarter worth approximately $26,000. Vermillion Wealth Management Inc. purchased a new stake in shares of Lam Research in the first quarter valued at approximately $26,000. Cedar Mountain Advisors LLC grew its holdings in Lam Research by 242.9% during the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company's stock worth $26,000 after acquiring an additional 85 shares during the period. Paladin Partners LLC purchased a new position in Lam Research in the second quarter worth $26,000. Finally, University of Illinois Foundation purchased a new position in Lam Research in the fourth quarter worth $30,000. Institutional investors and hedge funds own 84.61% of the company's stock.

Lam Research Price Performance

Shares of NASDAQ:LRCX traded up $7.39 during midday trading on Friday, hitting $347.49. 7,447,144 shares of the stock were exchanged, compared to its average volume of 10,799,794. The stock has a market cap of $434.86 billion, a P/E ratio of 60.33, a PEG ratio of 1.30 and a beta of 1.85. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30. Lam Research Corporation has a twelve month low of $131.02 and a twelve month high of $438.50. The company has a 50 day moving average price of $305.26 and a 200-day moving average price of $301.94.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm had revenue of $6.72 billion during the quarter, compared to the consensus estimate of $6.66 billion. During the same period in the previous year, the firm posted $1.33 EPS. The company's quarterly revenue was up 30.0% compared to the same quarter last year. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, research analysts forecast that Lam Research Corporation will post 9.32 earnings per share for the current year.

Lam Research Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 14th. Shareholders of record on Wednesday, September 23rd will be issued a $0.33 dividend. This is a boost from Lam Research's previous quarterly dividend of $0.26. The ex-dividend date is Wednesday, September 23rd. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.4%. Lam Research's dividend payout ratio (DPR) is 22.92%.

Insider Buying and Selling at Lam Research

In related news, Director Abhijit Y. Talwalkar sold 18,282 shares of the stock in a transaction on Monday, July 13th. The stock was sold at an average price of $335.00, for a total value of $6,124,470.00. Following the transaction, the director directly owned 87,142 shares of the company's stock, valued at approximately $29,192,570. This trade represents a 17.34% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 5,000 shares of Lam Research stock in a transaction on Monday, August 31st. The shares were sold at an average price of $302.46, for a total value of $1,512,300.00. Following the completion of the transaction, the insider owned 42,462 shares in the company, valued at $12,843,056.52. The trade was a 10.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 32,839 shares of company stock worth $10,644,740 in the last quarter. 0.31% of the stock is owned by insiders.

Analysts Set New Price Targets

LRCX has been the topic of several research analyst reports. Cantor Fitzgerald set a $500.00 target price on shares of Lam Research and gave the stock an "overweight" rating in a research report on Monday, June 29th. Rothschild & Co Redburn increased their price target on shares of Lam Research from $305.00 to $420.00 and gave the company a "buy" rating in a report on Wednesday, June 17th. Mizuho decreased their price objective on shares of Lam Research from $370.00 to $365.00 and set an "outperform" rating on the stock in a report on Tuesday, August 25th. Berenberg Bank set a $420.00 target price on shares of Lam Research in a research report on Wednesday, September 9th. Finally, Wells Fargo & Company restated an "overweight" rating and set a $350.00 target price (down from $450.00) on shares of Lam Research in a research report on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Lam Research currently has a consensus rating of "Moderate Buy" and a consensus price target of $364.01.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Optimistic earnings outlook: An earnings preview argues that Lam Research’s rally could continue, supported by artificial-intelligence infrastructure spending and sustained demand for wafer-fabrication equipment. Investors are likely watching for evidence that growth will remain strong in the next report. Lam Research: This Rally Has Legs (Earnings Preview)
• Positive Sentiment: Analyst support: B. Riley raised its price target from $350 to $390 and maintained a “buy” rating. Bank of America’s designation of LRCX as a top pick also reinforces the view that equipment demand may be stronger than previously expected. Does Lam Research Being a BofA Top Pick Reframe Its Equipment Demand Narrative?
• Positive Sentiment: Strong financial performance: Lam’s latest quarterly results exceeded expectations, with earnings of $1.82 per share versus a $1.69 consensus estimate and revenue of $6.72 billion. Revenue increased 30% year over year, while the company also raised its dividend, strengthening the bullish case. Lam Research Stock Gains Ground on Strong Earnings and Dividend Hike

Lam Research Profile

Lam Research Corporation is a semiconductor equipment company that designs, manufactures, and services systems used in the fabrication of integrated circuits and other electronic devices. Its equipment supports key steps in the wafer manufacturing process, helping semiconductor producers create increasingly small and complex features on silicon wafers.

The company's portfolio includes systems for etch, deposition, wafer cleaning, surface preparation, and related manufacturing processes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.